相关实验视频
Updated: Sep 12, 2025

08:18
Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
17.2K
癌症中的细胞衰老:从机制悖论到精确治疗方法
Tiejun Feng1,2,3, Fuda Xie1,2,3, Leo M Y Lee4
1Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong, China.
Molecular cancer
|August 9, 2025
概括
细胞衰老可以抑制或促进癌症. 本综述探讨了其在各种癌症中的双重作用,并强调了针对癌症进展的新疗法,如老化药物.
科学领域:
- 癌症生物学 癌症生物学
- 细胞衰老 细胞衰老
- 瘤微环境 瘤微环境
背景情况:
- 细胞衰老最初通过阻止受损细胞的增殖,作为一种抑制瘤的机制.
- 然而,持续的衰老通过与衰老相关的分泌表型促进癌症的进展,抵抗和转移.
- 衰老的作用取决于环境,在多个器官系统中影响各种癌症类型.
研究的目的:
- 综合审查各种癌症衰老的分子机制.
- 阐明衰老在瘤抑制和促进中的双重作用.
- 突出针对细胞衰老的创新治疗策略.
主要方法:
- 对衰老的分子机制的系统审查.
- 对衰老在瘤抑制和促进中的上下文依赖作用的分析.
- 检查治疗创新,包括老化药物,老态药物和组合策略.
主要成果:
- 衰老表现出双重作用,既作为瘤抑制剂,又作为恶性瘤促进剂.
- 持续的衰老为一种促炎性,免疫抑制性瘤微环境提供燃料.
- 新的治疗方法,如 senolytics 和 senomorphics 显示出癌症治疗的希望.
结论:
- 利用衰老为癌症治疗提供了变革性的潜力.
- 需要精准医学方法来克服诸如非目标效应和异质性等挑战.
- 未来的研究应该专注于调节衰老及其微环境,以有效治疗癌症.
相关概念视频
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Telomeres and Telomerase
5.4K
5.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Overview of DNA Repair
31.6K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Chemically...
31.6K

